Investor Presentaiton
Solid organic growth of 8% in H1 2022/23 with solid momentum across
business areas and geographies, excluding China
H1 2022/23 revenue by business area
H1 2022/23 revenue by geography
Business
area
Ostomy Care
Continence Care
Reported revenue FY
DKKm
Organic growth Share of organic
Geographic
FY
growth
area
4,478
7%
36%
European
markets
6%
29%
3,951
Reported revenue FY
DKKm
FY
Organic growth Share of organic
growth
6,878
6%
43%
Voice &
9%
3%
Respiratory Care*
959
Other developed
markets
3,187
11%
36%
Wound & Skin
1,425
7%
12%
Care
Emerging
markets
2,101
9%
21%
Interventional
1,353
14%
20%
Urology
Coloplast
Group
*Part of organic growth since February 1, 2023
54
12,166
8%
100%
Coloplast
Group
12,166
8%
100%
ColoplastView entire presentation